*  Most recent papers with the keyword Systemic hypertension treatment | Read by QxMD
... specifically angiotensin II converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB), have confirmed ... either alone or combined with angiotensin II type 1 antagonists on alterations induced by two-kidney, one-clip (2K1C) ... Effect of renin-angiotensin system inhibitors on survival in kidney transplant recipients: A systematic review and meta- ... Renin-angiotensin system activation promotes oxidative stress and endothelial dysfunction. However, no previous study has ...
  https://www.readbyqxmd.com/keyword/64546
*  A randomized controlled study to compare the effects of angiotensin II type 1 receptor blockers (telmisartan vs candesartan vs...
A randomized controlled study to compare the effects of angiotensin II type 1 receptor blockers (telmisartan vs candesartan vs ... A randomized controlled study to compare the effects of angiotensin II type 1 receptor blockers (telmisartan vs candesartan vs ... on the markers of cardiovascular risk in hypertensive patients with type 2 diabetes mellitus Next Previous ... on the markers of cardiovascular risk in hypertensive patients with type 2 diabetes mellitus Completed ...
  http://adisinsight.springer.com/trials/700041375?error=cookies_not_supported&code=65c246fb-b801-4768-b74e-eae74cada74a
*  Mint-Losartan - Uses, Side Effects, Interactions - MedBroadcast.com
Losartan belongs to a family of medications known as angiotensin II receptor blockers. These medications are used in adults and ... Losartan belongs to a family of medications known as angiotensin II receptor blockers. These medications are used in adults and ... Losartan may also be taken by adults who have type 2 diabetes along with hypertension and protein in the urine (proteinuria). ... angiotensin converting enzyme inhibitors (ACEIs; e.g., captopril, lisinopril, ramipril) *other angiotensin receptor blockers ( ...
  http://www.medbroadcast.com/drug/getdrug/mint-losartan
*  Nephron Power: IN THE NEWS:- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.
Experimental studies implicate the role of the renin-angiotensin system, particularly angiotensin II type-1 and type-2 ... Of related interest is that both beta-blockers and calcium-antagonists went through episodes when they were though to cause ... IN THE NEWS:- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. ... Three types of positive ANCA are reported: C-ANCA, P-ANCA and atypical ANCA, based on the staining pattern of the neutrophils ...
  http://www.nephronpower.com/2010/06/in-news-angiotensin-receptor-blockade.html
*  Review: In diabetes, ACE-Is, but not ARBs, reduce mortality and major CV events compared with placebo or active treatment |...
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular ... Type 2 Diabetes Annals of Internal Medicine; 152 (5): ITC3-1 Peripheral Arterial Disease Annals of Internal Medicine; 146 (5): ... In patients with diabetes, do angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin II-receptor blockers (ARBs) ... Renin-Angiotensin System Blockade Therapy After Surgical Aortic Valve Replacement for Severe Aortic Stenosis: A Cohort Study ...
  http://annals.org/aim/article-abstract/1897122/review-diabetes-ace-arbs-reduce-mortality-major-cv-events-compared
*  Abstract 19071: Impact of Angiotensin Receptor Blocker on Development of Glucose Intolerance and New-onset Diabetes Mellitus in...
35.5%, p=0.047). In Kaplan-Meyer curve, there was no difference between the two groups (p=0.428, figure A). Also, in cox- ... Background; Angiotensin receptor blocker (ARB) is being extensively used to control hypertension. But, there have been limited ... Abstract 19071: Impact of Angiotensin Receptor Blocker on Development of Glucose Intolerance and New-onset Diabetes Mellitus in ... Abstract 19071: Impact of Angiotensin Receptor Blocker on Development of Glucose Intolerance and New-onset Diabetes Mellitus in ...
  http://circ.ahajournals.org/content/126/Suppl_21/A19071
*  Pharmacology definition - Angiotensin Receptor Blocker - Medical Zone
Angiotensin receptor blocker will act by binding and blocking angioten ... Angiotensin Receptor Blocker Angiotensin receptor blocker such as losartan, candensartan and valsartan are useful in treating ... There will be an inhibition of the action of angiotensin II. Blockage of angiotensin II function may lead to vasodilation and ... Surgery Definition - What types of fluids is considered in managing shock? * Surgery Definition - What types of blood should be ...
  http://www.medicalzone.net/pharmacology-definition---angiotensin-receptor-blocker.html
*  VA NEPHRON-D: Diabetes iN Nephropathy Study - Full Text View - ClinicalTrials.gov
standard treatment with angiotensin receptor blocker on the progression of kidney disease in individuals with Type 2 diabetes ... The use of an angiotensin receptor blocker (ARB) has been shown to decrease the risk of progression of kidney disease in two ... Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic ... CSP #565 - Combination Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor for Treatment of Diabetic ...
  https://clinicaltrials.gov/ct2/show/NCT00555217
*  Riva-Irbesartan - Uses, Side Effects, Interactions - MedBroadcast.com
Irbesartan is used to lower blood pressure and decrease the rate of the progression of kidney damage in patients with type 2 ... Irbesartan belongs to a family of medicines known as angiotensin II receptor blockers. These medicines are used to lower high ... Irbesartan belongs to a family of medicines known as angiotensin II receptor blockers. These medicines are used to lower high ... have experienced a serious allergic reaction to another angiotensin II receptor blocker (ARB) (e.g., candesartan, losartan, ...
  http://www.medbroadcast.com/drug/getdrug/riva-irbesartan
*  The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute...
Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ... Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant ... and angiotensin receptor blockers were considered, and all ACE inhibitors and angiotensin receptor blockers used in clinical ... Blockade of the renin-angiotensin system using angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers ...
  http://www.bmj.com/content/344/bmj.e42
*  Angiotensin II receptor blocker - Wikipedia
Angiotensin II Type 1 Receptor Blockers at the US National Library of Medicine Medical Subject Headings (MeSH). ... Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists , AT1 receptor antagonists or ... They block the activation of AT1 receptors, preventing the binding of angiotensin II. Angiotensin II receptor blockers are used ... In a study comparing beta-blocker carvedilol with valsartan, the angiotensin II receptor blocker not only had no deleterious ...
  https://en.wikipedia.org/wiki/Angiotensin_II_receptor_blocker
*  Angiotensin II type 1 receptor blockers. - Semantic Scholar
3-9 With saralasin, it became possible to demonstrate that angiotensin II receptor blockade, alone or in combination with salt ... angiotensin II-like effects. The next major breakthrough in the understanding of the renin-angiotensin system was triggered by ... a nonselective peptidic antagonist of angiotensin II receptors. ... heart failure by a specific blockade of the renin-angiotensin ... the development of orally active angiotensin-converting enzyme (ACE) inhibitors.10-15 Studies performed with these agents ...
  https://www.semanticscholar.org/paper/Angiotensin-II-type-1-receptor-blockers.-Burnier/47afacff33df8b6edb024487f655ef7788708f86
*  The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic...
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic ... an angiotensin II type 1 receptor blocker (ARB), on ambulatory BP profiles and renal function in hypertensive CKD patients. ... 1.50±1.37, P=0.005; urinary type IV collagen excretion, 0.87±0.42 vs. 1.48±0.87, P=0.014) despite comparable A/B ratios for the ... Furthermore, the A/B ratios of urinary protein, albumin and type IV collagen excretion in the olmesartan add-on group were ...
  http://www.biomedsearch.com/nih/angiotensin-II-type-1-receptor/23154587.html
*  Angiotensin II type 1 receptor blockers lower IOP in mice and reduce TGFβ signaling in retinal ganglion cells | IOVS | ARVO...
Purpose : Angiotensin II type 1 receptor blockers (ARBs) are commonly used to treat systemic hypertension. In addition to ... Angiotensin II type 1 receptor blockers lower IOP in mice and reduce TGFβ signaling in retinal ganglion cells ... Angiotensin II type 1 receptor blockers lower IOP in mice and reduce TGFβ signaling in retinal ganglion cells ... Ralph J Hazlewood, John Kuchtey, Rachel W Kuchtey; Angiotensin II type 1 receptor blockers lower IOP in mice and reduce TGFβ ...
  http://iovs.arvojournals.org/article.aspx?articleid=2641875
*  Altex - Angiotensin II Type 1 Receptor Blockers, Angiotensin-Converting Enzyme Inhibitors, ATC:C09CA07
Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). ... Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, ... Telmisartan is an orally active nonpeptide angiotensin II antagonist that acts on the AT1 receptor subtype. New studies suggest ... Telmisartan works by blocking the vasoconstrictor and aldosterone secretory effects of angiotensin II. ...
  http://pharmacycode.com/Altex.html
*  The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes -...
... or angiotensin receptor blocker (ARB) may experience a decreased incidence of new-onset type 2 diabetes. ... The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes. 7 ... The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes. ... two trials), or heart failure (two trials), reductions in new-onset type 2 diabetes were maintained (0.79 [0.72-0.85], 0.76 [ ...
  http://www.thaiendocrine.org/en/2017/08/07/the-impact-of-ace-inhibitors-or-angiotensin-ii-type-1-receptor-blockers-on-the-development-of-new-onset-type-2-diabetes/
*  Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan ...
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Molecular Mechanisms of Pharmacological Action. ...
  https://clinicaltrials.gov/ct2/show/NCT00219180
*  Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients - Full Text View -...
Angiotensin Receptor Antagonists. Antihypertensive Agents. Angiotensin II Type 1 Receptor Blockers. Molecular Mechanisms of ... Although angiotensin receptor blockers (ARBs) are effective for patients with diabetes and chronic kidney disease in reducing ... Suzuki H, Kanno Y, Sugahara S, Ikeda N, Shoda J, Takenaka T, Inoue T, Araki R. Effect of angiotensin receptor blockers on ... Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients. The safety and ...
  https://clinicaltrials.gov/show/NCT00530595
*  Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension - Full Text View - ClinicalTrials.gov
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Anti-Arrhythmia Agents. Diuretics. Natriuretic ... Calcium Channel Blockers. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasodilator Agents. ... Therapy with a fixed-dose combination of two active medications represents two drugs). ... Stage 2 Systolic Hypertension Drug: valsartan, amlodipine, HCTZ Drug: Losartan, HCTZ followed by valsartan, amlodipine, HCTZ ...
  https://clinicaltrials.gov/show/NCT00931710
*  Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension - Full Text View - ClinicalTrials.gov
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. To Top. *For Patients and Families ... Calcium Channel Blockers. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasodilator Agents. ... Time Frame: 24±2 weeks ]. Percentage of patients achieving target blood pressure SBP/DBP ,140/90 mmHg is a key secondary ... Time Frame: baseline and 24±2 weeks ]. The primary endpoint is the mean blood pressure change SBP from baseline after 24±2 ...
  https://clinicaltrials.gov/ct2/show/study/NCT01316419?term=%22High+Blood+Pressure%22&lup_s=08%2F15%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14&show_locs=Y
*  FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry) - Full Text View - ClinicalTrials...
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Molecular Mechanisms of Pharmacological Action. ... Calcium Channel Blockers. Membrane Transport Modulators. Vasodilator Agents. Tocolytic Agents. Reproductive Control Agents. ... Type 1 diabetes mellitus. *Known cardiovascular disease including history of angina pectoris, heart failure, history of ... Treated with other antihypertensive medication except diuretics or beta-blockers. * ...
  https://clinicaltrials.gov/ct2/show/NCT01071122?term=%22High+Blood+Pressure%22&lup_s=01%2F26%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14
*  DIabetic Retinopathy Candesartan Trials. - Full Text View - ClinicalTrials.gov
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Molecular Mechanisms of Pharmacological Action. ... Genetics Home Reference related topics: Type 1 diabetes MedlinePlus related topics: Diabetes Type 1 Diabetic Eye Problems ... This study is part of the DIRECT Programme also including a primary prevention study of diabetic retinopathy in type 1 diabetes ... Male or female aged 18 - 55 years with type 1 diabetes diagnosed before age of 36 years and in need for continuous insulin ...
  https://www.clinicaltrials.gov/ct2/show/NCT00252720?term=DIRECT+candesartan&rank=1
*  Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age - Full Text View - ClinicalTrials.gov
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Diuretics. Natriuretic Agents. Physiological Effects ... Patients taking any of the following concomitant medications following screening: Renin-angiotensin receptor(RAAS) blockers ... Calcium Channel Blockers. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasodilator Agents. ... Current diagnosis of heart failure (New York Heart Association Class II-IV) ...
  https://clinicaltrials.gov/show/NCT01365481
*  Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients. - Full...
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Molecular Mechanisms of Pharmacological Action. ... Study Type:. Interventional Study Design:. Intervention Model: Single Group Assignment. Masking: None (Open Label). Primary ... After 1-week screening period, all of the eligible patients receive valsartan 80mg/day for 2 weeks, then the dosage will be ... Each subject will receive HBPM at baseline, week 2, week 6 and week 10 respectively.For baseline HBPM, it was performed in the ...
  https://clinicaltrials.gov/ct2/show/NCT01541189